Signatera
Showing 1 - 24 of 24
NSCLC, Stage III Trial in Indianapolis (Signatera ctDNA test)
Not yet recruiting
- NSCLC, Stage III
- Signatera ctDNA test
-
Indianapolis, IndianaIndiana University Melvin and Bren Simon Comprehensive Cancer Ce
Mar 13, 2023
ctDNA in Resectable and Borderline Resectable Pancreatic Cancer
Recruiting
- Pancreatic Cancer
- SIGNATERA™ ctDNA testing
-
Fairfax, VirginiaInova Schar Cancer Institute
Oct 26, 2022
Metastatic Colorectal Cancer Trial in Gainesville (Signatera ctDNA assay, pre-specified sequence of FDA-approved drugs and drug
Recruiting
- Metastatic Colorectal Cancer
- Signatera ctDNA assay
- pre-specified sequence of FDA-approved drugs and drug combinations
-
Gainesville, FloridaUniversity of Florida
Aug 9, 2022
Ovarian Cancer Recurrence Using Circulating Tumor DNA to Assess
Not yet recruiting
- Epithelial Ovarian Cancer
- Signatera testing
- Altera Testing
- (no location specified)
Jan 14, 2022
Stage III Colon Cancer Trial in Pittsburgh (Signatera test, mFOLFOX6 3-6 month, CAPOX 3 month)
Recruiting
- Stage III Colon Cancer
- Signatera test
- +5 more
-
Pittsburgh, PennsylvaniaNRG Oncology - Pittsburgh Center
Mar 30, 2022
Colon Adenocarcinoma, Colorectal Cancer Trial in Orange (drug, combination product, diagnostic test)
Recruiting
- Colon Adenocarcinoma
- Colorectal Cancer
- TAS-102
- +3 more
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University of Californi
May 24, 2022
BESPOKE Study of ctDNA Guided Immunotherapy
Recruiting
- Colorectal Cancer
- +2 more
-
San Carlos, CaliforniaNatera
Sep 10, 2021
Colorectal Cancer, Colon Cancer Trial in San Carlos
Recruiting
- Colorectal Cancer
- Colon Cancer
-
San Carlos, CaliforniaSan Carlos
Sep 15, 2021
Older Women With ER+ Breast Cancer Who Omit Surgery
Recruiting
- Breast Cancer
-
Pittsburgh, PennsylvaniaUPMC Magee Womens Hospital - Surgical Oncology
Jun 13, 2023
Melanoma Recurrence With Circulating Tumor DNA (ctDNA)
Active, not recruiting
- Melanoma
-
Murray, Utah
- +1 more
Feb 17, 2023
Breast Cancer, Early-Onset Trial in United States (Neoadjuvant chemo administered before surgical extraction of a tumor,
Active, not recruiting
- Breast Cancer, Early-Onset
- Neoadjuvant chemotherapy administered before surgical extraction of a tumor
- Observational
-
Elizabeth, New Jersey
- +11 more
Nov 29, 2022
Gastrooesophageal Cancer Trial in United Kingdom (Trastuzumab deruxtecan)
Not yet recruiting
- Gastrooesophageal Cancer
- Trastuzumab deruxtecan
-
Southampton, Hampshire, United Kingdom
- +16 more
Jul 27, 2023
Adenocarcinoma Esophagus Trial in Milwaukee (Circulating tumor DNA(ctDNA) level measurement)
Recruiting
- Adenocarcinoma Esophagus
- Circulating tumor DNA(ctDNA) level measurement
-
Milwaukee, WisconsinFroedtert Hospital and the Medical College of Wisconsin
May 23, 2022
Circulating Tumor DNA to Monitor Efficacy of Total Neoadjuvant
Not yet recruiting
- Colorectal Cancer
- Rectal Cancer
- SignateraTM assay
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jan 5, 2023
Locally Advanced Intrahepatic Cholangiocarcinoma, Oligometastatic Intrahepatic Cholangiocarcinoma, Stage III Intrahepatic
Not yet recruiting
- Locally Advanced Intrahepatic Cholangiocarcinoma
- +4 more
- Angiography
- +8 more
-
Jacksonville, FloridaMayo Clinic in Florida
Sep 22, 2023
Uveal Melanoma Trial in Pittsburgh (Tebentafusp)
Not yet recruiting
- Uveal Melanoma
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Oct 5, 2023
Locally Advanced Rectal Carcinoma, Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v8 Trial in Los Angeles (drug, radiation,
Recruiting
- Locally Advanced Rectal Carcinoma
- +9 more
- Capecitabine
- +7 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Jan 13, 2022
Nonsmall Cell Lung Cancer Trial in New York (Durvalumab, Tremelimumab)
Not yet recruiting
- Nonsmall Cell Lung Cancer
-
New York, New YorkColumbia University Irving Medical Center
Apr 29, 2022
Circulating Tumor DNA Alterations in Non-small Cell Lung Cancer
Recruiting
- Non Small Cell Lung Cancer
- Observational
-
New York, New YorkColumbia University Irving Medical Center, Herbert Irving Compre
Apr 7, 2022
Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Urothelial Carcinoma AJCC v6 and v7, Stage III Bladder Urothelial
Not yet recruiting
- Muscle Invasive Bladder Urothelial Carcinoma
- +3 more
- Biospecimen Collection
- +7 more
- (no location specified)
Aug 10, 2023
Breast Cancer Trial in London (ctDNA)
Not yet recruiting
- Breast Cancer
- ctDNA
-
London, United KingdomThe Royal Marsden NHS Foundation Trust
Sep 17, 2021
Improve Organ Preserving Strategies in Rectal Cancer
Recruiting
- Rectal Adenocarcinoma
- +8 more
- Biopsy
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
Nov 30, 2022
Appendix Carcinoma by AJCC V8 Stage, Colorectal Carcinoma by AJCC V8 Stage, Digestive System Tumor Trial in New Brunswick
Recruiting
- Appendix Carcinoma by AJCC V8 Stage
- +6 more
- Biospecimen Collection - blood and tissue sample collection
- Electronic Health Record Review
-
Livingston, New Jersey
- +1 more
Nov 16, 2022